These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8547069)
41. [The risk factors for early anemia in premature infants]. Sekretar LB Lik Sprava; 1998 Aug; (6):114-7. PubMed ID: 9844893 [TBL] [Abstract][Full Text] [Related]
42. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media. Shaw PH; Olszewski M; Kletzel M J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314 [TBL] [Abstract][Full Text] [Related]
43. Endogenous haemopoietic growth factors in neutropenia and infection. Cebon J; Layton JE; Maher D; Morstyn G Br J Haematol; 1994 Feb; 86(2):265-74. PubMed ID: 7515265 [TBL] [Abstract][Full Text] [Related]
44. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery. Bailie KE; Irvine AE; Bridges JM; McClure BG Pediatr Res; 1994 Feb; 35(2):164-8. PubMed ID: 7513077 [TBL] [Abstract][Full Text] [Related]
45. The in vitro effects of stem cell factor and PIXY321 on myeloid progenitor formation (CFU-GM) from immunomagnetic separated CD34+ cord blood. Cairo MS; Law P; van de Ven C; Plunkett JM; Williams D; Ishizawa L; Gee A Pediatr Res; 1992 Sep; 32(3):277-81. PubMed ID: 1383918 [TBL] [Abstract][Full Text] [Related]
46. Circulating steel factor (SLF) and G-CSF levels in preterm and term newborn and adult peripheral blood. Cairo MS; Gillan ER; Buzby JS; van de Ven C; Suen Y Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):311-5. PubMed ID: 7687097 [TBL] [Abstract][Full Text] [Related]
47. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394 [TBL] [Abstract][Full Text] [Related]
48. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Broxmeyer HE; Hangoc G; Cooper S; Ribeiro RC; Graves V; Yoder M; Wagner J; Vadhan-Raj S; Benninger L; Rubinstein P Proc Natl Acad Sci U S A; 1992 May; 89(9):4109-13. PubMed ID: 1373894 [TBL] [Abstract][Full Text] [Related]
49. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. Laver J; Duncan E; Abboud M; Gasparetto C; Sahdev I; Warren D; Bussel J; Auld P; O'Reilly RJ; Moore MA J Pediatr; 1990 Apr; 116(4):627-32. PubMed ID: 1690796 [TBL] [Abstract][Full Text] [Related]
50. [Hematopoietic growth factors]. Robak T Postepy Hig Med Dosw; 1991; 45(6):461-96. PubMed ID: 1726024 [TBL] [Abstract][Full Text] [Related]
51. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity. Lachance C; Chessex P; Fouron JC; Widness JA; Bard H J Pediatr; 1994 Aug; 125(2):278-82. PubMed ID: 8040778 [TBL] [Abstract][Full Text] [Related]
52. Colony-stimulating activity of fetal liver cells: synergistic role of stem cell factor in bone marrow recovery from aplastic anemia. Raju GM; Guha S; Mukhopadhyay A; Kumar L; Kale VP; Mittal S; Deka D; Mohanty S; Kochupillai V J Hematother Stem Cell Res; 2003 Oct; 12(5):491-7. PubMed ID: 14594505 [TBL] [Abstract][Full Text] [Related]
53. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor. Sieff C; Guinan E Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316 [TBL] [Abstract][Full Text] [Related]
54. Current controversies in the management of the anemia of prematurity. Bishara N; Ohls RK Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579 [TBL] [Abstract][Full Text] [Related]
55. The anemia of prematurity and the decision when to transfuse. Stockman JA Adv Pediatr; 1983; 30():191-219. PubMed ID: 6369939 [No Abstract] [Full Text] [Related]
56. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture. Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332 [TBL] [Abstract][Full Text] [Related]
57. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone. Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570 [TBL] [Abstract][Full Text] [Related]
58. Hematopoietic growth factors: Part I. Wolfe M; Wandstrat TL Neonatal Netw; 1996 Sep; 15(6):7-11. PubMed ID: 8932067 [TBL] [Abstract][Full Text] [Related]
59. The effect of cytokines on CD34+ Rh-123high and low progenitor cells from human umbilical cord blood. Cicuttini FM; Welch KL; Boyd AW Exp Hematol; 1994 Dec; 22(13):1244-51. PubMed ID: 7525327 [TBL] [Abstract][Full Text] [Related]
60. Serum erythropoietin and granulocyte-macrophage-colony stimulating factor levels with megadose methylprednisolone treatment. Sayli TR; Ozsoylu S Turk J Pediatr; 1996; 38(4):491-5. PubMed ID: 8993179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]